Oral azithromycin,oral and intravenous erythromycin treatment of respiratory tract mycoplasma infection curative effect and adverse reaction of contrast
10.3969/j.issn.1005-1678.2017.07.134
- VernacularTitle:口服阿奇霉素、口服及静脉红霉素治疗呼吸道支原体感染疗效及不良反应对比
- Author:
Yuna LE
;
Jianlie GU
- Keywords:
oral azithromycin;
oral erythromycin;
venous erythromycin;
respiratory tract mycoplasma infection;
clinical curative effect;
adverse reactions
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(7):325-326,329
- CountryChina
- Language:Chinese
-
Abstract:
Objective To summarize analysis of respiratory tract mycoplasma infection in patients with oral azithromycin,oral and intravenous erythromycin treatment the clinical effect and safety.Methods From April 2014 to September 2016 received during the period of 120 patients with respiratory tract mycoplasma infection as the research object,were randomly divided into oral azithromycin, oral erythromycin group and intravenous erythromycin group,all patients were retrospectively analyzed the clinical therapeutic effects and adverse reactions occur.Results The total effective rate in treatment,oral azithromycin is higher than oral and intravenous treatment of erythromycin,Signs and symptoms in the incidence of adverse reactions and improve the time aspect,oral azithromycin is lower than the oral and intravenous treatment of erythromycin,diff there is statistical significance(P<0.05).Conclusion For respiratory tract mycoplasma infection adopt oral azithromycin compared with oral and intravenous erythromycin treatment,the effect is better,shorter symptom improvement,higher security,worthy of clinical popularization and application.
